Bristol-Myers Squibb Company v. ScieGen Pharmaceuticals, Inc.
1:23-cv-00393
Overview
Case Number
1:23-cv-00393
Filing Date
2023-04-06
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Gregory B. Williams
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT for PATENT INFRINGEMENT filed against ScieGen Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4107837.) - filed by Bristol-Myers Squibb Company and Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/10/2023)
2023-04-06
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 04/10/2023)
2023-04-06
1
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/4/2023. Date of Expiration of Patent: 2/24/2031.Thirty Month Stay Deadline: 9/4/2025. (mkr) (Entered: 04/10/2023)
2023-04-06
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (mkr) (Entered: 04/10/2023)
2023-04-06
1